CacyBP/SIP promotes the proliferation of colon cancer cells

被引:19
作者
Zhai, Huihong [1 ,2 ]
Shi, Yongquan [1 ]
Chen, Xiong [1 ]
Wang, Jun [1 ]
Lu, Yuanyuan [1 ]
Zhang, Faming [1 ]
Liu, Zhengxiong [1 ]
Lei, Ting [1 ]
Fan, Daiming [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
CALCYCLIN-BINDING-PROTEIN; TUMOR PROMOTER; GASTRIN; TRANSLOCATION; DEGRADATION; PROTEOLYSIS; P27(KIP1); PATHWAY; GROWTH; MECHANISMS;
D O I
10.1371/journal.pone.0169959
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CacyBP/SIP is a component of the ubiquitin pathway and is overexpressed in several transformed tumor tissues, including colon cancer, which is one of the most common cancers worldwide. It is unknown whether CacyBP/SIP promotes the proliferation of colon cancer cells. This study examined the expression level, subcellular localization, and binding activity of CacyBP/SIP in human colon cancer cells in the presence and absence of the hormone gastrin. We found that CacyBP/SIP was expressed in a high percentage of colon cancer cells, but not in normal colonic surface epithelium. CacyBP/SIP promoted the cell proliferation of colon cancer cells under both basal and gastrin stimulated conditions as shown by knockdown studies. Gastrin stimulation triggered the translocation of CacyBP/SIP to the nucleus, and enhanced interaction between CacyBP/SIP and SKP1, a key component of ubiquitination pathway which further mediated the proteasome-dependent degradation of p27(kip1) protein. The gastrin induced reduction in p27(kip1) was prevented when cells were treated with the proteasome inhibitor MG132. These results suggest that CacyBP/SIP may be promoting growth of colon cancer cells by enhancing ubiquitin-mediated degradation of p27(kip1).
引用
收藏
页数:16
相关论文
共 40 条
[1]   Duel nature of TGF-β signaling:: tumor suppressor vs. tumor promoter [J].
Bachman, KE ;
Park, BH .
CURRENT OPINION IN ONCOLOGY, 2005, 17 (01) :49-54
[2]   SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box [J].
Bai, C ;
Sen, P ;
Hofmann, K ;
Ma, L ;
Goebl, M ;
Harper, JW ;
Elledge, SJ .
CELL, 1996, 86 (02) :263-274
[3]   INHIBITION OF GASTRIN-INDUCED PROLIFERATION OF AR4-2J CELLS BY CALCIUM-CHANNEL ANTAGONISTS [J].
BERTRAND, V ;
BASTIE, MJ ;
VAYSSE, N ;
PRADAYROL, L .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :427-432
[4]   Diet, Genes, and Microbes: Complexities of Colon Cancer Prevention [J].
Birt, Diane F. ;
Phillips, Gregory J. .
TOXICOLOGIC PATHOLOGY, 2014, 42 (01) :182-188
[5]   The genetics of colorectal cancer [J].
Calvert, PM ;
Frucht, H .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (07) :603-612
[6]   SIRT1, Is It a Tumor Promoter or Tumor Suppressor? [J].
Deng, Chu-Xia .
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (02) :147-152
[7]  
Fan DN, 2008, SHIJIE HUAREN XIAOHU, V16, P3953, DOI [10.3969/j.issn.1009-3079.2008.35.005, DOI 10.3969/J.ISSN.1009-3079.2008.35.005]
[8]   Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin [J].
Filipek, A ;
Kuznicki, J .
JOURNAL OF NEUROCHEMISTRY, 1998, 70 (05) :1793-1798
[9]   Ca2+-dependent translocation of the calcyclin-binding protein in neurons and neuroblastoma NB-2a cells [J].
Filipek, A ;
Jastrzebska, B ;
Nowotny, M ;
Kwiatkowska, K ;
Hetman, M ;
Surmacz, L ;
Wyroba, E ;
Kuznicki, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :21103-21109
[10]   Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders [J].
Garcia-Ibarbia, Carmen ;
Delgado-Calle, Jesus ;
Casafont, Inigo ;
Velasco, Javier ;
Arozamena, Jana ;
Perez-Nunez, Maria I. ;
Alonso, Maria A. ;
Berciano, Maria T. ;
Ortiz, Fernando ;
Perez-Castrillon, Jose L. ;
Fernandez, Agustin F. ;
Fraga, Mario F. ;
Zarrabeitia, Maria T. ;
Riancho, Jose A. .
GENE, 2013, 532 (02) :165-172